Measurement of glutathione in normal volunteers and stroke patients at 3T using J-difference spectroscopy with minimized subtraction errors

Journal of Magnetic Resonance Imaging

Volumn 30, Issue 2, 2009, Pages 263-270

  An, Li ^a,c   Zhang, Yan ^b   Thomasson, David M ^c   Latour, Lawrence L ^a   Baker, Eva H ^c   Shen, Jun ^b   Warach, Steven ^a  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^b NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Glutathione; J difference; Spectral registration; Stroke; Subtraction errors

Indexed keywords

GLUTATHIONE; N ACETYLASPARTIC ACID;

ADULT; ARTICLE; ARTIFACT REDUCTION; BRAIN LEVEL; CLINICAL ARTICLE; COMPUTER ANALYSIS; COMPUTER SIMULATION; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; FEMALE; GLUTATHIONE BRAIN LEVEL; HUMAN; IN VIVO STUDY; J DIFFERENCE SPECTROSCOPY; MALE; MEASUREMENT ERROR; PHANTOM; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; SIGNAL DETECTION; SPECTROSCOPY; STROKE; STROKE PATIENT;

ADULT; ASPARTIC ACID; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHOLINE; CREATINE; FEMALE; GLUTATHIONE; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; PHANTOMS, IMAGING; SIGNAL PROCESSING, COMPUTER-ASSISTED; STROKE; SUBTRACTION TECHNIQUE;

EID: 68049123602     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.21832     Document Type: Article

References (22)

1. Shimizu H, Kiyohara Y, Kato I, et al. Relationship between plasma glutathione levels and cardiovascular disease in a defined population: the Hisayama study. Stroke 2004;35:2072-2077. (Pubitemid 39129563)
2. Zimmermann C, Winnefeld K, Streck S, Roskos M, Haberl RL. Antioxidant status in acute stroke patients and patients at stroke risk. Eur Neurol 2004;51:157-161. (Pubitemid 38608316)
3. 1H magnetic resonance spectroscopy. Magn Reson Med 2002;48:949-958.
4. 1H MRS. Magn Reson Med 2003;49:632-637.
5. Trabesinger AH, Weber OM, Duc CO, Boesiger P. Detection of glutathione in the human brain in vivo by means of double quantum coherence filtering. Magn Reson Med 1999;42:283-289. (Pubitemid 29364707)
6. Trabesinger AH, Boesiger P. Improved selectivity of double quantum coherence filtering for the detection of glutathione in the human brain in vivo. Magn Reson Med 2001;45:708-710. (Pubitemid 32260094)
7. Terpstra M, Henry PG, Gruetter R. Measurement of reduced glutathione (GSH) in human brain using LCModel analysis of difference-edited spectra. Magn Reson Med 2003;50:19-23. (Pubitemid 36841855)
8. Satoh T, Yoshioka Y. Contribution of reduced and oxidized glutathione to signals detected by magnetic resonance spectroscopy as indicators of local brain redox state. Neurosci Res 2006;55:34-39.
9. Zhao T, Heberlein K, Jonas C, Jones DP, Hu X. New double quantum coherence filter for localized detection of glutathione in vivo. Magn Reson Med 2006;55:676-680. (Pubitemid 43352568)
10. An L, Zhang Y, Thomasson DM, et al. Practical glutathione measurement in human brain at 3 T. In: Proceedings of the 16th Annual Meeting of ISMRM, Toronto, Ontario, Canada, 2008 (Abstract 1640).
11. Choi C, Coupland NJ, Seres P, et al. Detection of glutathione in human brain in vivo by yield-enhanced double-quantum filtering at 3T. In: Proceedings of the 16th Annual Meeting of ISMRM, Toronto, Ontario, Canada, 2008 (Abstract 688).
12. Matsuzawa D, Obata T, Shirayama Y, et al. Negative correlation between brain glutathione level and negative symptoms in schizophrenia: a 3T 1H-MRS study. PLoS ONE 2008;3:e1944. (Pubitemid 352003354)
13. Srinivasan R, Nelson S, Hammond K, et al. Indication of oxidative stress in multiple sclerosis using proton MR spectroscopic imaging at 7T. In: Proceedings of the 16th Annual Meeting of ISMRM, Toronto, Ontario, Canada, 2008 (Abstract 509).
14. Choi IY, Lee SP, Merkle H, Shen J. Single-shot two-echo technique for simultaneous measurement of GABA and creatine in the human brain in vivo. Magn Reson Med 2004;51:1115-1121. (Pubitemid 38796995)
15. Keltner JR, Wald LL, Christensen JD, et al. A technique for detecting GABA in the human brain with PRESS localization and optimized refocusing spectral editing radiofrequency pulses. Magn Reson Med 1996;36:458-461.
16. Waddell KW, Avison MJ, Joers JM, Gore JC. A practical guide to robust detection of GABA in human brain by J-difference spectroscopy at 3 T using a standard volume coil. Magn Reson Imaging 2007;25:1032-1038.
17. Smith SA, Levante TO, Meier BH, Ernst RR. Computer simulations in magnetic resonance. An object oriented programming approach. J Magn Reson 1994;106a:75-105.
18. Edden RA, Pomper MG, Barker PB. In vivo differentiation of N-acetyl aspartyl glutamate from N-acetyl aspartate at 3 Tesla. Magn Reson Med 2007;57:977-982.
19. Kreis R, Ernst T, Ross BD. Development of the human brain: in vivo quantification of metabolite and water content with proton magnetic resonance spectroscopy. Magn Reson Med 1993;30:424-437. (Pubitemid 23300070)
20. Longo R, Bampo A, Vidimari R, Magnaldi S, Giorgini A. Absolute quantitation of brain 1H nuclear magnetic resonance spectra. Comparison of different approaches. Invest Radiol 1995;30:199-203.
21. Bland JM, Altman DG. Measurement error. BMJ 1996;313:744.
22. Schubert F, Gallinat J, Seifert F, Rinneberg H. Glutamate concentrations in human brain using single voxel proton magnetic resonance spectroscopy at 3 Tesla. Neuroimage 2004;21:1762-1771. (Pubitemid 38446596)